Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - fièvre hémorragique À virus ebola - vaccins - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - le myélome multiple - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - le myélome multiple - agents antinéoplasiques - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international nv - canagliflozine - diabète sucré, type 2 - les médicaments utilisés dans le diabète - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 et 5.

Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international n.v. - darunavir, le cobicistat - infections au vih - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta, est indiqué en association avec d'autres médicaments antirétroviraux pour le traitement de l'infection par le virus de l'immunodéficience humaine 1 (vih 1) chez les adultes âgés de 18 ans ou plus. les tests génotypiques devrait guider l'utilisation de rezolsta.

Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international nv - rilpivirine - infections au vih - antiviraux à usage systémique - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.

Ufaransa - Kifaransa - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

janssen cilag - chlorhydrate d'oxybutynine - comprimé - 5 mg - composition pour un comprimé > chlorhydrate d'oxybutynine : 5 mg - medicament urologique/antispasmodique urinaire

Ufaransa - Kifaransa - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

janssen cilag - dompéridone - comprimé - 10 mg - composition pour un comprimé > dompéridone : 10 mg - stimulants de la motricité intestinale

Ufaransa - Kifaransa - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

janssen cilag - chlorhydrate d'oxybutynine - comprimé - 15 mg - composition pour un comprimé > chlorhydrate d'oxybutynine : 15 mg - medicament urologique/antispasmodique urinaire

Ufaransa - Kifaransa - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

janssen cilag - chlorhydrate d'oxybutynine - comprimé - 10 mg - composition pour un comprimé > chlorhydrate d'oxybutynine : 10 mg - medicament urologique/antispasmodique urinaire